Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption

Osteoporosis International

Volumn 3, Issue 5, 1993, Pages 255-260

  Eastell, R ^a   Robins, S P ^b   Colwell, T ^a   Assiri, A M A ^a   Riggs, B L ^c   Russell, R G G ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ROWETT RESEARCH INSTITUTE   (United Kingdom)

^c MAYO CLINIC   (United States)

Author keywords

Bone remodelling; Collagen; Osteocalcin; Osteoporosis; Pyridinium crosslinks

Indexed keywords

BIOCHEMICAL MARKER; COLLAGEN; HYDROXYPROLINE; OSTEOCALCIN; PYRIDINIUM DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BONE TURNOVER; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; HUMAN; HUMAN EXPERIMENT; MAJOR CLINICAL STUDY; NORMAL HUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; POSTMENOPAUSE; URINARY EXCRETION;

AGED; AMINO ACIDS; BIOLOGICAL MARKERS; BONE DEVELOPMENT; BONE RESORPTION; FEMALE; HUMAN; HYDROXYPROLINE; MIDDLE AGE; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027328906     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/BF01623829     Document Type: Article

References (37)

1. Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers
2. Serum bone-gla protein: a specific marker for bone formation in postmenopausal osteoporosis
3. Estimation of bone turnover evaluated by45Ca-kinetics: efficiency of bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion
4. Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein
5. Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: effects of sex, age, and metabolic bone disease
6. Estimation of whole body bone resorption rate: a comparison of urinary total hydroxyproline excretion with two radioisotopic tracer methods in osteoporosis
7. Correlation of urinary hydroxyproline, serum alkaline phosphatase and skeletal calcium turnover
8. Isotopic studies on collagen degradation and the urine excretion of hydroxyproline
9. An enzyme-linked immunoassay for the collagen crosslink pyridinoline
10. Quantitation of hydroxypyridinium crosslinks in collagen by high performance liquid chromatography
11. Changes with age in the urinary excretion of lysyl- and hydroxylysylpyridinoline, two new markers of bone collagen turnover
12. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease
13. Analysis of pyridinoline, a cross-linking compound of collagen fibres, in human urine
14. Effect of diet on deoxypyridinoline excretion
15. Direct measurement of free hydroxypyridinium crosslinks of collagen in urine as new markers of bone resorption in osteoporosis
16. Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis
17. Diagnostic evaluation of osteoporosis
18. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography
19. Nyctohemeral changes in bone turnover assessed by serum bone Gla-protein concentration and urinary deoxypyridinoline excretion: effects of growth and ageing
20. Increase in serum bone gamma-carboxyglutamic acid protein with aging in women
21. Liquid chromatographic determination of total hydroxyproline in urine
22. Cancellous bone remodelling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels
23. Bone turnover in spinal osteoporosis
24. Impaired osteoblast function in metabolic bone disease
25. Bone remodelling and calcium metabolism: a correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget's disease
26. Urinary hydroxyproline levels in an aged population: a study of non-osteoporotic and osteoporotic patients
27. Histological heterogeneity of apparently idiopathic osteoporosis
28. Bone formation and resorption as the determinants of trabecular bone volume in postmenopausal osteoporosis
29. Postmenopausal osteoporosis: a heterogeneous disorder as assessed by histomorphometric analysis of iliac crest bone from untreated patients
30. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis
31. Urinary collagen crosslinks are highly correlated with radioisotopic measurements of bone resorption
32. Treatment of osteoporosis
33. Prediction of rapid bone loss in postmenopausal women
34. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium crosslinks
35. Bone loss and biochemical indices of bone remodelling in surgically induced postmenopausal women
36. Commentary: prediction of bone loss in postmenopausal women